Andreea I. Varga
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 20, 2025
First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors.
Journal: Cancer
Published: November 08, 2024
Factors influencing trust among colleagues in hospital settings: a systematic review.
Journal: BMC health services research
Published: May 06, 2024
Trustworthy management in hospital settings: a systematic review.
Journal: BMC health services research
Published: August 29, 2022
Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score.
Journal: Cancers
Published: July 20, 2022
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 31, 2021
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 24, 2021
Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 05, 2020
PD-1 Blockade in Anaplastic Thyroid Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 05, 2020
Patterns of progression in patients treated for immuno-oncology antibodies combination.
Journal: Cancer immunology, immunotherapy : CII
Published: November 06, 2019
Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapies.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 05, 2019
Last Updated: 09/26/2026